The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Abstract
Hyperphosphorylated microtubule-associated protein tau is the major component of the paired helical filament of Alzheimer's disease. Phosphorylation-dependent anti-tau antibodies are being used to identify specific amino acids that are phosphorylated in tau from normal brain and Alzheimer's disease brain. As such, monoclonal antibody AT8 is widely used. By a combination of site-directed mutagenesis of recombinant tau and in vitro phosphorylation, we show that AT8 requires tau protein to be phosphorylated at both serine 202 and threonine 205 (using the numbering of the longest human brain tau isoform.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, no significant difference was observed between PS19 and PS19;ApoeCh mice at both 5 and 9 mo of age (Fig. 5a-d, Supp. Figure 14a-c) [45, 67–69].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [67]
In the citing paper
“AT8, which recognizes Tau that is phosphorylated at Ser202 and Thr205 (Goedert et al., 1995) or Ser199, Ser202, and Thr205 (Hanger et al., 2009).”
From Regulation of Mitochondrial Transport and Inter-Microtubule Spacing by Tau Phosphorylation at the Sites Hyperphosphorylated in Alzheimer's Disease (2012) · cites this paper as Goedert et al., 1995
In the citing paper
“their detection by this antibody is commonly used as a marker of abnormal phosphorylation in brains of Alzheimer's patients.”
From Regulation of Mitochondrial Transport and Inter-Microtubule Spacing by Tau Phosphorylation at the Sites Hyperphosphorylated in Alzheimer's Disease (2012) · cites this paper as Goedert et al., 1995
Citations
Cites
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citationA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929
Self-citationBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citationSutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
Self-citationMatsuo, E. S., Shin, R., Billingsley, M., de Voorde, A. V., O'Connor, M., Trojanowski, J., & Lee, V. (1994) · Neuron · doi:10.1016/0896-6273(94)90264-x · Cited by 588
Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.
Drewes, G., Lichtenberg‐Kraag, B., Döring, F., Mandelkow, E. M., Biernat, J., Goris, J., Dorée, M., & Mandelkow, E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05272.x · Cited by 565
Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau
Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515
Research works printed but not linked: 1
- Trojanowski, 1993, PHF-Tau (A68): From pathological marker to potential mediator of neuronal dysfunction and de generation in Alzheimer's disease, Clin. Neurosci., 1, 184191
Cited by
Sorted by citations
Items 201–300 of 610
Age-related progression of tau pathology in brains of baboons
Schultz, C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00176-7 · Cited by 84
van Herpen, E., Rosso, S. M., Serverijnen, L., Yoshida, H., Breedveld, G. J., van de Graaf, R., Kamphorst, W., Ravid, R., Willemsen, R., Dooijes, D., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10721 · Cited by 83
Self-citationHärtig, W., Stieler, J., Boerema, A. S., Wolf, J., Schmidt, U., Weißfuß, J., Bullmann, T., Strijkstra, A. M., & Arendt, T. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05250.x · Cited by 83
Wang, Y., Chen, G.-H., Hu, X., Lu, Y.-P., Zhou, J., & Liu, R. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.061 · Cited by 80
An okadaic acid-induced model of tauopathy and cognitive deficiency
Zhang, Z., & Simpkins, J. W. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.077 · Cited by 82
Accelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model
Ando, K., Leroy, K., Héraud, C., Yilmaz, Z., Authelet, M., Suain, V., Decker, R. D., & Brion, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.034 · Cited by 80
Hellström‐Lindahl, E., Moore, H., & Nordberg, A. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740777.x · Cited by 81
Takao, M., Ghetti, B. F., Hayakawa, I., Ikeda, E., Fukuuchi, Y., Miravalle, L., Piccardo, P., Murrell, J. R., Glazier, B. S., & Koto, A. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0536-6 · Cited by 81
Merrick, S. E., Demoise, D. C., & Lee, V. M. ‐. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5589 · Cited by 81
Héraud, C., Goufak, D., Ando, K., Leroy, K., Suain, V., Yilmaz, Z., De Decker, R., Authelet, M., Laporte, V., Octave, J.-N., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.010 · Cited by 80
Planel, E., Krishnamurthy, P., Miyasaka, T., Liu, L., Herman, M., Kumar, A., Bretteville, A., Figueroa, H. Y., Haung Yu, W., Whittington, R. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-08.2008 · Cited by 79
Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders
Härtig, W., Klein, C., Brauer, K., Schüppel, K.-F., Arendt, T., Brückner, G., & Bigl, V. (2000) · Acta Neuropathologica · doi:10.1007/s004010000183 · Cited by 79
Takao, M., Benson, M. D., Murrell, J. R., Yazaki, M., Piccardo, P., Unverzagt, F. W., Davis, R. L., Holohan, P. D., Lawrence, D. A., Richardson, R., et al. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1070 · Cited by 78
Spillantini, M. G., Tolnay, M., Love, S., & Goedert, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051034 · Cited by 78
Self-citationThe extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
Yuste‐Checa, P., Trinkaus, V. A., Riera-Tur, I., Imamoglu, R., Schaller, T., Wang, H., Dudanova, I., Hipp, M. S., Bracher, A., & Hartl, F. U. (2021) · Nature Communications · doi:10.1038/s41467-021-25060-1 · Cited by 78
Muñoz, D. G., Woulfe, J., & Kertesz, A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0266-x · Cited by 77
Ryan, S. D., Whitehead, S. N., Swayne, L. A., Moffat, T. C., Hou, W., Ethier, M., Bourgeois, A. J. G., Rashidian, J., Blanchard, A. P., Fraser, P. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905654106 · Cited by 74
In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy
Crescenzi, R., DeBrosse, C., Nanga, R. P. R., Reddy, S., Haris, M., Hariharan, H., Iba, M., Lee, V. M. Y., Detre, J. A., Borthakur, A., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.067 · Cited by 73
Disruption of the cytoskeleton in Alzheimer's disease
Lee, V. M. ‐. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80073-5 · Cited by 75
Chapter 21 Neurofibrillary pathology of Alzheimer's disease and other tauopathies
Goedert, M. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64022-4 · Cited by 77
Self-citationMatsumura, N., Yamazaki, T., & Ihara, Y. (1999) · American Journal of Pathology · doi:10.1016/s0002-9440(10)65420-x · Cited by 81
Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis
Delobel, P., Flament, S., Hamdane, M., Vanbesien-Mailliot, C., Sambo, A., Bégard, S., Sergeant, N., Delacourte, A., Vilain, J., & Buée, L. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01143.x · Cited by 73
Zhou, K., Yuan, C., Dai, B., Wang, K., Chen, Y., Ma, D., Dai, J., Liang, Y., Tan, H., & Cui, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00672 · Cited by 73
Augustinack, J. C., Sanders, J. L., Tsai, L., & Hyman, B. T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.6.557 · Cited by 74
Wilhelmsen, K. C., Forman, M. S., Rosen, H. J., Alving, L. I., Goldman, J. S., Feiger, J., Lee, J. V., Segall, S. K., Kramer, J. H., Lomen, C. E., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.398 · Cited by 73
Kimura, T., Tsutsumi, K., Taoka, M., Saito, T., Masuda‐Suzukake, M., Ishiguro, K., Plattner, F., Uchida, T., Isobe, T., Hasegawa, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433326 · Cited by 73
Furcila, D., DeFelipe, J., & Alonso‐Nanclares, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180173 · Cited by 73
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Lantero‐Rodriguez, J., Montoliu‐Gaya, L., Benedet, A. L., Vrillon, A., Dumurgier, J., Cognat, E., Brum, W. S., Rahmouni, N., Stevenson, J., Servaes, S., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02659-w · Cited by 74
Audouard, E., Houben, S., Masaracchia, C., Yilmaz, Z., Suain, V., Authelet, M., Decker, R. D., Buée, L., Boom, A., Leroy, K., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.008 · Cited by 73
Kim, D., Su, J. H., & Cotman, C. W. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01724-2 · Cited by 72
Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
Weston, L. L., Jiang, S., Chisholm, D., Jantzie, L. L., & Bhaskar, K. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02211-1 · Cited by 69
Landrieu, I., Smet‐Nocca, C., Amniai, L., Louis, J. V., Wieruszeski, J., Goris, J., Janssens, V., & Lippens, G. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021521 · Cited by 71
García‐Sierra, F., Hauw, J. J., Duyckaerts, C. J., Wischik, C. M., Luna‐Muñoz, J., & Mena, R. (2000) · Acta Neuropathologica · doi:10.1007/s004010051189 · Cited by 69
Nübling, G., Bader, B., Levin, J., Hildebrandt, J., Kretzschmar, H. A., & Giese, A. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-35 · Cited by 69
Postmortem changes in the phosphorylation state of tau-protein in the rat brain
Gärtner, U., Janke, C., Holzer, M., Vanmechelen, E., & Arendt, T. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00094-3 · Cited by 66
Self-citationThe Environmental Toxin Arsenite Induces Tau Hyperphosphorylation
Giasson, B. I., Sampathu, D. M., Wilson, C., Vogelsberg-Ragaglia, V., Mushynski, W. E., & Lee, V. M. ‐. (2002) · Biochemistry · doi:10.1021/bi026813c · Cited by 66
Hyperphosphorylated Tau is Elevated in Alzheimer's Disease with Psychosis
Murray, P. S., Kirkwood, C. M., Gray, M. C., Fish, K. N., Ikonomović, M. D., Hamilton, R. L., Kofler, J., Klunk, W. E., López, O. L., & Sweet, R. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131166 · Cited by 67
Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice
Bayod, S., Felice, P., Andrés‐Benito, P., Rosa, P., Camins, A., Pallàs, M., & Canudas, A.-M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.017 · Cited by 63
β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
Wu, H., Kuo, P.-C., Wang, Y.-T., Lin, H.-T., Roe, A. D., Wang, B. Y., Han, C., Hyman, B. T., Chen, Y., & Tai, H. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly059 · Cited by 72
Phosphorylation and cleavage of tau in non-AD tauopathies
Guillozet-Bongaarts, A. L., Glajch, K. E., Libson, E. G., Cahill, M. E., Bigio, E. H., Berry, R. W., & Binder, L. I. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0209-6 · Cited by 65
The interrelationship between selective tau phosphorylation and microtubule association
Xie, H., Litersky, J. M., Hartigan, J. A., Jope, R. S., & Johnson, G. V. W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00407-7 · Cited by 66
N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein
Ando, K., Uemura, K., Kuzuya, A., Maesako, M., Asada-Utsugi, M., Kubota, M., Aoyagi, N., Yoshioka, K., Okawa, K., Inoue, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158477 · Cited by 66
rAAV-based brain slice culture models of Alzheimer’s and Parkinson’s disease inclusion pathologies
Croft, C. L., Cruz, P. E., Ryu, D. H., Ceballos‐Diaz, C., Strang, K. H., Woody, B. M., Lin, W.-L., Deture, M. A., Rodríguez-Lebrón, E., Dickson, D. W., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182184 · Cited by 65
Formation of Phospho-SAPK/JNK Granules in the Hippocampus Is an Early Event in Alzheimer Disease
Lagalwar, S., Guillozet-Bongaarts, A. L., Berry, R. W., & Binder, L. I. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229236.98124.d8 · Cited by 62
Kulnane, L. S., & Lamb, B. T. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0446 · Cited by 63
Alzheimer disease without neocortical neurofibrillary tangles
Tiraboschi, P., Sabbagh, M. N., Hansen, L. A., Salmon, D. P., Merdes, A., Gamst, A. C., Masliah, E., Alford, M. F., Thal, L. J., & Corey‐Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000118212.41542.e7 · Cited by 62
Puri, R., Suzuki, T., Yamakawa, K., & Ganesh, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009688 · Cited by 60
Tau Function and Dysfunction in Neurons
Ávila, J., Lim, F., Moreno, F. J., Belmonte, C., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:3:213 · Cited by 63
Gandhi, N. S., Landrieu, I., Byrne, C., Kukić, P., Amniai, L., Cantrelle, F., Wieruszeski, J., Mancera, R. L., Jacquot, Y., & Lippens, G. M. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201501898 · Cited by 59
Murayama, H., Shin, R., Higuchi, J., Shibuya, S., Muramoto, T., & Kitamoto, T. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65187-5 · Cited by 59
p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice
Walls, K. C., Ager, R. R., Vasilevko, V., Cheng, D., Medeiros, R., & LaFerla, F. M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.047 · Cited by 62
Ether stress‐induced Alzheimer‐like tau phosphorylation in the normal mouse brain
Ikeda, Y., Ishiguro, K., & Fujita, S. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.064 · Cited by 57
Mondragón‐Rodríguez, S., Mena, R., Binder, L. I., Smith, M. A., Perry, G. L., & García‐Sierra, F. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00853.x · Cited by 60
Yadikar, H., Torres, I., Aiello, G., Kurup, M., Yang, Z., Lin, F. Y., Kobeissy, F. H., Yost, R. A., & Wang, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224952 · Cited by 58
Takahashi, M., Weidenheim, K. M., Dickson, D. W., & Ksiezak-Reding, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.1.33 · Cited by 56
Vanbesien-Mailliot, C., Podevin-Dimster, V., Rosenthal, R. E., Sergeant, N., Delacourte, A., Fiskum, G. M., & Buée, L. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00013 · Cited by 57
Spinal Cord Neurofibrillary Pathology in Alzheimer Disease and Guam Parkinsonism-Dementia Complex
Schmidt, M. L., Zhukareva, V. A., Perl, D. P., Sheridan, S. K., Schuck, T., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.11.1075 · Cited by 55
Chronic Administration of Dimebon Ameliorates Pathology in Tau P301S Transgenic Mice
Peters, O. M., Connor‐Robson, N., Sokolov, V. B., Aksinenko, A. Y., Kukharsky, M. S., Бачурин, С. О., Ninkina, N. N., & Buchman, V. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121732 · Cited by 54
Tau phosphorylation in a mouse model of temporal lobe epilepsy.
Alves, M., Kenny, A., de Leo, G., Beamer, E. H., & Engel, T. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00308 · Cited by 54
Drepper, F., Biernat, J., Kaniyappan, S., Meyer, H. E., Mandelkow, E., Warscheid, B., & Mandelkow�, E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015882 · Cited by 56
Tolnay, M., & Probst, A. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00250-x · Cited by 54
Wagner, U., Brownlees, J., Irving, N. G., Lucas, F. R., Salinas, P. C., & Miller, C. C. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00733-3 · Cited by 53
Hung, K.-S., Hwang, S.-L., Ling, C.-L., Chen, Y.-J., Lee, T.-H., Liu, J. K., Howng, S., & Wang, C. H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.1.15 · Cited by 53
Melis, V., Zabke, C., Stamer, K., Magbagbeolu, M., Schwab, K., Marschall, P., Veh, R. W., Bachmann, S., Deiana, S., Moreau, P., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1804-z · Cited by 53
Maurage, C.-A., Sergeant, N., Ruchoux, M.-M., Hauw, J.-J., & Delacourte, A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0608-7 · Cited by 51
Strang, K. H., Goodwin, M. S., Riffe, C. J., Moore, B. D., Chakrabarty, P., Levites, Y., Golde, T. E., & Giasson, B. I. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0458-0 · Cited by 53
Dugger, B. N., Hidalgo, J. A., Chiarolanza, G., Mariner, M., Henry-Watson, J., Sue, L. I., & Beach, T. G. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121864 · Cited by 53
Silva, M. C., Nandi, G., Donovan, K. A., Cai, Q., Berry, B. C., Nowak, R. P., Fischer, E. S., Gray, N. S., Ferguson, F. M., & Haggarty, S. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.801179 · Cited by 51
Hestiantoro, A., & Swaab, D. F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030862 · Cited by 51
Takao, M., Ghetti, B. F., Murrell, J. R., Unverzagt, F. W., Giaccone, G., Tagliavini, F., Bugiani, O., Piccardo, P., Hulette, C. M., Crain, B. J., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1137 · Cited by 51
Binder, J., Ursu, O., Bologa, C., Jiang, S., Maphis, N., Dadras, S., Chisholm, D., Weick, J., Myers, O., Kumar, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03068-7 · Cited by 49
Perez, S. E., Miguel, J. C., He, B., Malek‐Ahmadi, M. H., Abrahamson, E. E., Ikonomović, M. D., Lott, I. T., Doran, E. W., Alldred, M. J., Ginsberg, S. D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01965-6 · Cited by 48
Ishizawa, K., Komori, T., Shimazu, T., Yamamoto, T., Kitamoto, T., Shimazu, K., & Hirose, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0547-3 · Cited by 49
Fujii, H., Takahashi, T., Mukai, T., Tanaka, S., Hosomi, N., Maruyama, H., Sakai, N., & Matsumoto, M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16668889 · Cited by 48
Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold
Qi, C., Verheijen, B. M., Kokubo, Y., Shi, Y., Tetter, S., Murzin, A. G., Nakahara, A., Morimoto, S., Vermulst, M., Sasaki, R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306767120 · Cited by 51
Self-citationMammeri, N. E., Dregni, A. J., Duan, P., & Hong, M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316175121 · Cited by 54
Phospho-Tau Changes in the Human CA1 During Alzheimer’s Disease Progression
Regalado-Reyes, M., Furcila, D., Hernández, F., Ávila, J., DeFelipe, J., & León‐Espinosa, G. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181263 · Cited by 50
Tolnay, M., Mistl, C., Ipsen, S., & Probst, A. (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00090.x · Cited by 47
Lambourne, S. L., Sellers, L. A., Bush, T. G., Choudhury, S. K., Emson, P. C., Suh, Y., & Wilkinson, L. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.278-293.2005 · Cited by 47
Reduction of DHHC5-mediated beclin 1 S-palmitoylation underlies autophagy decline in aging
Guo, R., Liu, J., Min, X., Zeng, W., Shan, B., Zhang, M., He, Z., Zhang, Y., He, K., Yuan, J., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01163-9 · Cited by 46
Marcon, G., Giaccone, G., Cupidi, C., Balestrieri, M., Beltrami, C. A., Finato, N., Bergonzi, P., Sorbi, S., Bugiani, O., & Tagliavini, F. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.3.199 · Cited by 46
Härtig, W. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00179-2 · Cited by 46
Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions
Rutherford, N. J., Lewis, J. M., Clippinger, A. K., Thomas, M. A., Adamson, J. L., Cruz, P. E., Cannon, A. D., Xu, G. M., Golde, T. E., Shaw, G., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.006 · Cited by 46
Zhang, B., Yao, Y., Cornec, A., Oukoloff, K., James, M. J., Koivula, P. P., Trojanowski, J. Q., Smith, A. B., Lee, V. M. ‐., Ballatore, C., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0291-3 · Cited by 46
Rüb, U., Tredici, K. D., Schultz, C., Büttner-Ennever, J. A., & Braak, H. (2001) · Vision Research · doi:10.1016/s0042-6989(01)00090-6 · Cited by 44
Gong, C., Shaikh, S., Grundke, I., & Iqbal, K. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00904-3 · Cited by 44
Goñi, F., Herline, K., Peyser, D., Wong, K., Ji, Y., Sun, Y., Mehta, P., & Wisniewski, T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-150 · Cited by 43
Small Vascular and Alzheimer Disease-Related Pathologic Determinants of Dementia in the Oldest-Old
Sinka, L., Kövari, E., Gold, G., Hof, P. R., Herrmann, F. R., Bouras, C., & Giannakopoulos, P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ffc3b9 · Cited by 44
Perez, S. E., Getova, D. P., He, B., Counts, S., Geula, C., Désiré, L., Coutadeur, S., Peillon, H., Ginsberg, S. D., & Mufson, E. J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.027 · Cited by 43
Lionnet, A., Wade, M. A., Corbillé, A.-G., Prigent, A., Paillusson, S., Tasselli, M., Gonzales, J. A., Durieu, E., Rolli‐Derkinderen, M., Coron, E., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0568-3 · Cited by 45
Lesort, M. J., Blanchard, C., Yardin, C., Esclaire, F., & Hugon, J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00284-7 · Cited by 43
Picalm reduction exacerbates tau pathology in a murine tauopathy model
Ando, K., Decker, R. D., Vergara, C., Yilmaz, Z., Mansour, S., Suain, V., Sleegers, K., de Fisenne, M.-A., Houben, S., Potier, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02125-x · Cited by 46
Li, L., Liang, J., & Fu, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.020 · Cited by 42
Rodríguez, J. L., Oltmer, J., Greve, D. N., Williams, E. M., Slepneva, N., Wang, R., Champion, S., Lang-Orsini, M., Fischl, B. R., Frosch, M. P., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215567 · Cited by 44
Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice
G??tz, J., & Nitsch, R. M. (2001) · Neuroreport · doi:10.1097/00001756-200107030-00045 · Cited by 42
Mann, D. M. A., Takeuchi, A., Sato, S., Cairns, N. J., Lantos, P. L., Rossor, M. N., Haltia, M., Kalimo, H., & Iwatsubo, T. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00316.x · Cited by 42
Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer’s disease brainPreprint
Ding, Q., Shults, N. V., Harris, B. T., & Suzuki, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.08.331157 · Cited by 42
Schultz, M. K., Gentzel, R. C., Usenovic, M., Gretzula, C. A., Ware, C., Parmentier‐Batteur, S., Schachter, J. B., & Zariwala, H. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.003 · Cited by 45
Cisternas, P., Lindsay, C. B., Salazar, P. L., Silva-Álvarez, C., Retamales-Ortega, R., Serrano, F. G., Vio, C. P., & Inestrosa, N. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.009 · Cited by 42
Miller, N., Feng, Z., Edens, B. M., Yang, B., Shi, H., Sze, C. C., Hong, B. T., Su, S. C., Cantú, J. A., Topczewski, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3716-14.2015 · Cited by 41
Metadata
- Authors
- Goedert, M., Jakes, R., & Vanmechelen, E.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Fujirebio (Belgium) (BE)
- Corresponding author
- Goedert, M.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 1995-04
- Volume
- 189
- Issue
- 3
- Pages
- 167-170
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2062772621
- Cited by
- 608
- References
- 24
- Citations by year
- 2026: 36 · 2025: 33 · 2024: 20 · 2023: 30 · 2022: 27 · 2021: 26 · 2020: 20 · 2019: 20 · 2018: 20 · 2017: 15 · 2016: 12 · 2015: 22 · 2014: 12 · 2013: 17 · 2012: 14
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tau phosphorylation, paired helical filaments, Alzheimer's disease, anti-tau antibodies, site-directed mutagenesis, in vitro phosphorylation
- MeSH terms
- Amino Acid Sequence, Antibodies, Monoclonal, Cloning, Molecular, Escherichia coli, Humans, Molecular Sequence Data, Phosphorylation, Protein Kinases, Recombinant Proteins, Serine, Threonine, tau Proteins, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review